Wed May 9, 2012 3:35pm BST (Reuters) – Pluristem Therapeutics Inc said a 7-year old girl suffering from a bone marrow disease experienced a reversal of her condition after receiving its experimental stem cell therapy, sending the Israeli company’s shares up 32 percent. Continue reading →